长非编码RNA PTCSC3-AS1与PTCSC3在14q13.3甲状腺癌位点通过波形蛋白协同调控ZC3H12A mRNA稳定性
研究在14q13.3位点发现未注释的长非编码RNA PTCSC3-AS1,其在乳头状甲状腺癌(PTC)肿瘤组织中表达下调,恢复其表达可抑制肿瘤发生并促进细胞凋亡。PTCSC3-AS1与PTCSC3通过共享结合蛋白波形蛋白协同保护ZC3H12A mRNA免受降解,提示该双lncRNA调控网络参与PTC遗传易感性。
要点
- PTCSC3-AS1在PTC肿瘤组织中表达显著下调,恢复其表达可抑制肿瘤发生并促进凋亡。
- PTCSC3-AS1与PTCSC3通过共享结合蛋白波形蛋白协同作用,共同靶向下游ZC3H12A。
- 波形蛋白降低ZC3H12A mRNA稳定性,而PTCSC3和PTCSC3-AS1上调可抑制ZC3H12A mRNA降解。
核心结论
- 结果提示14q13.3风险位点存在一种新的双lncRNA调控模型,并全面注释了PTCSC3-AS1/PTCSC3-波形蛋白-ZC3H12A信号网络在PTC遗传易感性中的作用。
研究设计与样本
- 通过cDNA末端快速扩增法获得甲状腺中表达序列标签片段AA632637的全长序列。
- 采用定量逆转录PCR检测lncRNA在临床甲状腺组织和细胞系中的表达水平。
- 在体外和体内进行细胞增殖、迁移、侵袭和凋亡等功能实验。
- 采用RNA测序分析、放线菌素D实验、RNA pull-down、RNA免疫沉淀和双荧光素酶报告基因实验鉴定lncRNA结合靶点并揭示调控机制。
主要发现
- 在14q13.3位点内鉴定出一个先前未注释的lncRNA基因,命名为PTCSC3-AS1。
- PTCSC3-AS1在PTC肿瘤组织中表达强烈下调,在PTC细胞中恢复PTCSC3-AS1表达可抑制肿瘤发生并促进细胞凋亡。
- PTCSC3-AS1与PTCSC3位于14q13.3相反链,二者与共享结合蛋白波形蛋白协同相互作用。
- 强制过表达PTCSC3和PTCSC3-AS1显示ZC3H12A(经证实为PTC抑制基因)是这两个lncRNA的共同下游靶点。
- 波形蛋白显著降低ZC3H12A的mRNA稳定性,而PTCSC3和PTCSC3-AS1上调抑制ZC3H12A的mRNA降解。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: The 14q13.3 has been identified as a genetic locus associated with a genetically increased risk of papillary thyroid cancer (PTC) in several cohorts, yet its underlying regulatory mechanisms remain poorly understood. Methods: The full-length sequence of expressed sequence tag fragment AA632637 in the thyroid was obtained by rapid amplification of complementary DNA ends assay. Quantitative Reverse Transcription PCR (qRT-PCR) assays were utilized to examine the expression levels of the long noncoding RNA (lncRNA) in clinical thyroid tissues and cell lines. Functional assays, including cell proliferation, migration, invasion, and apoptosis assays, were conducted both in vitro and in vivo. Furthermore, RNA-seq analysis, actinomycin D assay, RNA pull-down, RNA immunoprecipitation, and dual-luciferase reporter assays were performed to identify the long noncoding RNA (lncRNA) binding targets and reveal the underlying regulatory mechanism. Results: We identified a previously unannotated lncRNA gene, named papillary thyroid carcinoma susceptibility candidate 3 antisense 1 (PTCSC3-AS1), within 14q13.3. The expression of PTCSC3-AS1 was strongly downregulated in PTC tumor tissues, and restoration of PTCSC3-AS1 expression in PTC cells inhibited tumorigenesis and promoted cell apoptosis. Moreover, PTCSC3-AS1 and PTCSC3, two lncRNAs located on the opposite strands at 14q13.3, were revealed to synergistically interact with their shared binding protein vimentin. Forced overexpression of PTCSC3 and PTCSC3-AS1 revealed that ZC3H12A, a gene validated as a PTC suppressor, was the shared downstream target of the two lncRNAs. Vimentin significantly reduced the mRNA stability of ZC3H12A, while the upregulation of PTCSC3 and PTCSC3-AS1 suppressed the mRNA degradation of ZC3H12A. In addition, rs944289 and rs116909374 were identified as two potential causative variants with distinct regulatory roles in the 14q13.3 locus. Mechanistically, PTCSC3-AS1 and PTCSC3 protected ZC3H12A from vimentin-mediated mRNA degradation by targeting the ZC3H12A 3' untranslated region (3'UTR) during PTC initiation and progression. Conclusion: Our results suggest a novel dual-lncRNA regulatory model in the 14q13.3 risk locus and provide a comprehensive annotation of the PTCSC3-AS1/PTCSC3-vimentin-ZC3H12A signaling network in PTC genetic predisposition.
引用
- Zhang Y, Shi X, Cheng S, et al. Long Noncoding RNAs Papillary Thyroid Carcinoma Susceptibility Candidate 3 Antisense 1 and Papillary Thyroid Carcinoma Susceptibility Candidate 3 Synergistically Regulate ZC3H12A mRNA Stability via Vimentin at 14q13.3 Thyroid Cancer Locus. Thyroid. 2025. PMID: 40376726. doi:10.1089/thy.2024.0674
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。